C. Benjamin Naman

Dr. C. Benjamin Naman

Li Dak Sum Marine Biopharmaceutical Research Center, Department of Marine Pharmacy, College of Food and Pharmaceutical Sciences, Ningbo University
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2017 in Journal of Natural Products
Verified
Journal Article
Closed access
C. Benjamin NamanC. Benjamin Naman
C. Benjamin Naman
RRRamandeep Rattan
Ramandeep Rattan
SNSvetlana E. Nikoulina
Svetlana E. Nikoulina
JLJohn Lee
John Lee
BMBailey W. Miller
Bailey W. Miller
WGWilliam Gerwick
William Gerwick


1 December 2019 in Cell Systems
Verified
Journal Article
Closed access
LCLiu Cao
Liu Cao
AGAlexey Gurevich
Alexey Gurevich
KAKelsey L. Alexander
Kelsey L. Alexander
C. Benjamin NamanC. Benjamin Naman
C. Benjamin Naman
TLTiago Leão
Tiago Leão
Hosein MohimaniHosein Mohimani
Hosein Mohimani

28 January 2020 in ACS Chemical Biology
Verified
Journal Article
Closed access
Lena KellerLena Keller
Lena Keller
KCKirley Marques Canuto
Kirley Marques Canuto
CLChenxi Liu
Chenxi Liu
BSBrian M. Suzuki
Brian M. Suzuki
JAJehad Almaliti
Jehad Almaliti
WGWilliam Gerwick
William Gerwick

2 April 2018 in ACS Chemical Neuroscience
Verified
Journal Article
Closed access
JWJialing Wang
Jialing Wang
JZJiachen Zheng
Jiachen Zheng
CHChunhui Huang
Chunhui Huang
JZJiaying Zhao
Jiaying Zhao
JLJiajia Lin
Jiajia Lin
SHShan He
Shan He

8 August 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
RRRaphael Reher
Raphael Reher
AAAllegra T. Aron
Allegra T. Aron
PFPavla Fajtová
Pavla Fajtová
PSPaolo Stincone
Paolo Stincone
BWBerenike Wagner
Berenike Wagner
DPDaniel Petras
Daniel Petras
The identity and biological activity of most metabolites still remain unknown. A bottleneck in the exploration of metabolite structures and pharmaceutical activities is the compound purification needed for bioactivity assignments and downstream structure elucidation. To enable bioactivity-focused compound identification from complex mixtures, we develop a scalable native metabolomics approach that integrates non-targeted liquid chromatography tandem mass spectrometry and detection of protein binding via native mass spectrometry. A native metabolomics screen for protease inhibitors from an environmental cyanobacteria community reveals 30 chymotrypsin-binding cyclodepsipeptides. Guided by the native metabolomics results, we select and purify five of these compounds for full structure elucidation via tandem mass spectrometry, chemical derivatization, and nuclear magnetic resonance spectroscopy as well as evaluation of their biological activities. These results identify rivulariapeptolides as a family of serine protease inhibitors with nanomolar potency, highlighting native metabolomics as a promising approach for drug discovery, chemical ecology, and chemical biology studies.